Amirouche A

Département de Psychiatrie et d'Addictologie, Hôpital Paul Brousse, Assistance Publique-Hôpitaux de Paris APHP, Villejuif, France.

9 papers · ORCID

ArticlePsilocybin

Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.

Strika-Bruneau L, Elhssaini C, Fauvel B +5

Europe PMC2026
ArticleMDMA

Psychometric validation of the French version of the five-dimensional altered states of consciousness questionnaire (5D-ASC) and associated 11 OAV subscales.

Kervadec E, Mathieu P, Fauvel B +6

Europe PMC2026
ArticleIbogaine

Thirty Years of Ibogaine Research: A Literature Review on Clinical Perspectives.

Kervadec E, Bezo A, Serreau R +5

Europe PMC2026
ArticlePsychedelics

Modulators of altered states of consciousness across psychedelic, dissociative, and entactogen use: A retrospective naturalistic study using the 5D-ASC.

Romeo B, Kervadec E, Fauvel B +7

Europe PMC2026
ArticlePsilocybin

Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.

Romeo B, Kervadec E, Fauvel B +5

Europe PMC2025
ArticlePsilocybin

The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.

Romeo B, Kervadec E, Fauvel B +5

Europe PMC2025
ArticlePsilocybin

Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.

Romeo B, Kervadec E, Fauvel B +5

Europe PMC2025
ArticlePsilocybin

Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.

Romeo B, Kervadec E, Fauvel B +5

Europe PMC2024
ArticlePsilocybin

A Review of Synthetic Access to Therapeutic Compounds Extracted from <i>Psilocybe</i>.

Serreau R, Amirouche A, Benyamina A +1

Europe PMC2022